Skip to content

13F-HR filed by Antara Capital LP

Antara Capital LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 2 holding rows worth $30,189.

Accession
0001172661-26-001155
Filed
2026-02-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2025

A holdings report, 2 entries on the cover page, a total value of $30,189 stated on the cover page (in dollars after the unit check, H1), rows summing to $30,189 with VALUE read as dollars as filed, 13F file number 028-19352. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ASPIRE BIOPHARMA HLDGS INC COM738920107Stock202,897$26,762dollars as filed
ASPIRE BIOPHARMA HLDGS INC738920115*W EXP 02/14/203207,693$3,427dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-26-001155this filing2026-02-17acceptance time not in the bulk data set